BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1930961)

  • 1. The antibacterial activity of a siderophore. 2. The influence of deferoxamine alone and combined with ascorbic acid on the activity of antibiotics against Staphylococcus aureus.
    Hartzen SH; Frimodt-Møller N; Thomsen VF
    APMIS; 1991 Oct; 99(10):879-86. PubMed ID: 1930961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibacterial activity of a siderophore. 3. The activity of deferoxamine in vitro and its influence on the effect of antibiotics against Escherichia coli, Proteus mirabilis and coagulase-negative staphylococci.
    Hartzen SH; Frimodt-Møller N; Thomsen VF
    APMIS; 1994 Mar; 102(3):219-26. PubMed ID: 8185889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibacterial activity of a siderophore. 1. In vitro activity of deferoxamine alone and in combination with ascorbic acid on Staphylococcus aureus.
    Hartzen SH; Frimodt-Møller N; Frølund Thomsen V
    APMIS; 1989 May; 97(5):419-24. PubMed ID: 2730787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of ascorbic acid on the antibacterial activity of selected antibiotics and synthetic chemotherapeutic agents in in vitro conditions].
    Belicová A; Dobias J; Ebringer L; Krajcovic J
    Ceska Slov Farm; 2000 May; 49(3):134-8. PubMed ID: 10953458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antistaphylococcal activity of teicoplanin in association with other antibiotics.
    Cruciani M; Concia E; Monzillo V; Marone P; Perversi L
    Microbiologica; 1987 Apr; 10(2):197-207. PubMed ID: 2953955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin.
    van Asbeck BS; Marcelis JH; van Kats JH; Jaarsma EY; Verhoef J
    Eur J Clin Microbiol; 1983 Oct; 2(5):432-8. PubMed ID: 6315421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
    Lemaire S; Kosowska-Shick K; Julian K; Tulkens PM; Van Bambeke F; Appelbaum PC
    Clin Microbiol Infect; 2008 Aug; 14(8):766-77. PubMed ID: 18727801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
    Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
    Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro study of strains of Staphylococcus: choice of an antibiotic].
    Messmer JC; Lecaillon-Thibon E; Soler H
    Sem Hop; 1984 May; 60(19):1329-32. PubMed ID: 6326323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro time-kill activities of rifalazil, alone and in combination with vancomycin, against logarithmic and stationary cultures of Staphylococcus aureus.
    Osburne MS; Rothstein DM; Farquhar R; Murphy CK
    J Antibiot (Tokyo); 2006 Feb; 59(2):80-5. PubMed ID: 16629407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibacterial sensitivity of Staphylococcus aureus isolated from clinical specimens].
    Ozsan M; Tan G; Ozenci H
    Mikrobiyol Bul; 1989 Jul; 23(3):246-50. PubMed ID: 2487465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergic interaction between pomegranate extract and antibiotics against Staphylococcus aureus.
    Braga LC; Leite AA; Xavier KG; Takahashi JA; Bemquerer MP; Chartone-Souza E; Nascimento AM
    Can J Microbiol; 2005 Jul; 51(7):541-7. PubMed ID: 16175202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.
    DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin.
    Tsuji BT; Rybak MJ
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):73-7. PubMed ID: 16368477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Short communication: Determination of methicillin resistance in staphylococci with different methods and detection of multiple antibiotic resistance].
    Cetinkol Y; Altindiş M; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2008 Jan; 42(1):119-24. PubMed ID: 18444569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiological indications for the treatment of Staphylococcus aureus infections.
    Fabbri A; Tacchella A; Belli ML; Losurdo G
    Chemioterapia; 1988 Dec; 7(6):378-81. PubMed ID: 3219748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of deferoxamine against Porphyromonas gingivalis.
    Moon JH; Herr Y; Kim SW; Lee JY
    FEMS Microbiol Lett; 2011 Oct; 323(1):61-7. PubMed ID: 22092680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kinetics of the anti-staphylococcal activity of bakuchiol in vitro (author's transl)].
    Kaul R
    Arzneimittelforschung; 1976 Apr; 26(4):486-9. PubMed ID: 989003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.